BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29466950)

  • 1. HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
    Soares PC; Abdelhay ES; Thuler LCS; Soares BM; Demachki S; Ferro GVR; Assumpção PP; Lamarão LM; Ribeiro Pinto LF; Burbano RMR
    BMC Gastroenterol; 2018 Feb; 18(1):30. PubMed ID: 29466950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
    Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
    Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
    Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus-related squamous cell carcinoma of the anal canal with papillary features.
    Leon ME; Shamekh R; Coppola D
    World J Gastroenterol; 2015 Feb; 21(7):2210-3. PubMed ID: 25717259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.
    Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR
    Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer.
    Koerber SA; Schoneweg C; Slynko A; Krug D; Haefner MF; Herfarth K; Debus J; Sterzing F; von Knebel Doeberitz M; Prigge ES; Reuschenbach M
    Radiother Oncol; 2014 Dec; 113(3):331-6. PubMed ID: 25465729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
    Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY
    Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal.
    Serup-Hansen E; Linnemann D; Skovrider-Ruminski W; Høgdall E; Geertsen PF; Havsteen H
    J Clin Oncol; 2014 Jun; 32(17):1812-7. PubMed ID: 24821878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma.
    Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; French D; Limiti MR; Ghini C; Vecchione A
    J Exp Clin Cancer Res; 1999 Mar; 18(1):47-52. PubMed ID: 10374676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
    Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
    Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal.
    Roldán Urgoiti GB; Gustafson K; Klimowicz AC; Petrillo SK; Magliocco AM; Doll CM
    PLoS One; 2014; 9(10):e108790. PubMed ID: 25271758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy.
    Gilbert DC; Williams A; Allan K; Stokoe J; Jackson T; Linsdall S; Bailey CM; Summers J
    Radiother Oncol; 2013 Oct; 109(1):146-51. PubMed ID: 24021343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.
    Meyer JE; Panico VJ; Marconato HM; Sherr DL; Christos P; Pirog EC
    J Gastrointest Cancer; 2013 Dec; 44(4):450-5. PubMed ID: 24014082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
    Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
    Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and virological characteristics of superficially invasive squamous-cell carcinoma of the anus.
    Arana R; Fléjou JF; Si-Mohamed A; Bauer P; Etienney I
    Colorectal Dis; 2015 Nov; 17(11):965-72. PubMed ID: 25784158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
    Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.